| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses S Jones, X Zhang, DW Parsons, JCH Lin, RJ Leary, P Angenendt, ... science 321 (5897), 1801-1806, 2008 | 4488 | 2008 |
| Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor … G Dranoff, E Jaffee, A Lazenby, P Golumbek, H Levitsky, K Brose, ... Proceedings of the National Academy of Sciences 90 (8), 3539-3543, 1993 | 3330 | 1993 |
| Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens AY Huang, P Golumbek, M Ahmadzadeh, E Jaffee, D Pardoll, H Levitsky Science 264 (5161), 961-965, 1994 | 1513 | 1994 |
| Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene S Jones, RH Hruban, M Kamiyama, M Borges, X Zhang, DW Parsons, ... Science 324 (5924), 217-217, 2009 | 927 | 2009 |
| Mechanisms of immune evasion by tumors CG Drake, E Jaffee, DM Pardoll Advances in immunology 90, 51-81, 2006 | 848 | 2006 |
| Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas identification of a new pancreatic cancer marker by Serial Analysis of Gene … P Argani, C Iacobuzio-Donahue, B Ryu, C Rosty, M Goggins, RE Wilentz, ... Clinical Cancer Research 7 (12), 3862-3868, 2001 | 695 | 2001 |
| Novel allogeneic granulocyte-macrophage colony-stimulating factor–secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation EM Jaffee, RH Hruban, B Biedrzycki, D Laheru, K Schepers, PR Sauter, ... Journal of Clinical Oncology 19 (1), 145-156, 2001 | 667 | 2001 |
| Compromised HOXA5 function can limit p53 expression in human breast tumours V Raman, SA Martensen, D Reisman, E Evron, WF Odenwald, E Jaffee, ... Nature 405 (6789), 974-978, 2000 | 627 | 2000 |
| Safety and survival with GVAX pancreas prime and Listeria monocytogenes–expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer DT Le, A Wang-Gillam, V Picozzi, TF Greten, T Crocenzi, G Springett, ... Journal of Clinical Oncology 33 (12), 1325-1333, 2015 | 609 | 2015 |
| Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer. DT Le, E Lutz, JN Uram, EA Sugar, B Onners, S Solt, L Zheng, LA Diaz Jr, ... Journal of immunotherapy (Hagerstown, Md.: 1997) 36 (7), 382-389, 2013 | 579 | 2013 |
| Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays CA Iacobuzio-Donahue, A Maitra, M Olsen, AW Lowe, NT Van Heek, ... The American journal of pathology 162 (4), 1151-1162, 2003 | 558 | 2003 |
| Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2 … JPH Machiels, RT Reilly, LA Emens, AM Ercolini, RY Lei, D Weintraub, ... Cancer research 61 (9), 3689-3697, 2001 | 543 | 2001 |
| Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer JW Simons, EM Jaffee, CE Weber, HI Levitsky, WG Nelson, MA Carducci, ... Cancer research 57 (8), 1537-1546, 1997 | 520 | 1997 |
| Immunotherapy converts nonimmunogenic pancreatic tumors into immunogenic foci of immune regulation ER Lutz, AA Wu, E Bigelow, R Sharma, G Mo, K Soares, S Solt, A Dorman, ... Cancer immunology research 2 (7), 616-631, 2014 | 479 | 2014 |
| The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product AY Huang, PH Gulden, AS Woods, MC Thomas, CD Tong, W Wang, ... Proceedings of the National Academy of Sciences 93 (18), 9730-9735, 1996 | 478 | 1996 |
| Recruitment of latent pools of high-avidity CD8+ T cells to the antitumor immune response AM Ercolini, BH Ladle, EA Manning, LW Pfannenstiel, TD Armstrong, ... The Journal of experimental medicine 201 (10), 1591-1602, 2005 | 464 | 2005 |
| The determinants of tumour immunogenicity T Blankenstein, PG Coulie, E Gilboa, EM Jaffee Nature Reviews Cancer 12 (4), 307-313, 2012 | 460 | 2012 |
| PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors KC Soares, AA Rucki, AA Wu, K Olino, Q Xiao, Y Chai, A Wamwea, ... Journal of Immunotherapy 38 (1), 1-11, 2015 | 428 | 2015 |
| A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma: a phase II trial of safety, efficacy … E Lutz, CJ Yeo, KD Lillemoe, B Biedrzycki, B Kobrin, J Herman, E Sugar, ... Annals of surgery 253 (2), 328, 2011 | 426 | 2011 |
| SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer A Blackford, OK Serrano, CL Wolfgang, G Parmigiani, S Jones, X Zhang, ... Clinical Cancer Research 15 (14), 4674-4679, 2009 | 424 | 2009 |
